ebook Munafa Stock Market Course + Intraday & FNO calls  

       

BLUE announcements Bluebird Bio, Inc. announcements and dividends declared USA

Bluebird Bio, Inc. Complete list of announcements declared & dividend announcements by Bluebird Bio, Inc. BLUE

Bluebird Bio, Inc. BLUE listed on USA and deals in Health Care Biotechnology Biological Products No Diagnostic Substances

Announcements and dividends declared by Bluebird Bio, Inc. BLUE

Bluebird Bio Chief Strategy And Financial Officer Jason Cole To Resign
(RTTNews) - bluebird bio, Inc. (BLUE) announced that Jason Cole, Chief Strategy and Financial Officer, plans to leave the company. Cole's last day will be October 14, 2022. Over the coming weeks, Cole plans to transition finance responsibilities to Katheri
Announcement as on 12 September 2022

Why Bluebird Bio's Stock Dived by Over 11% This Week
What happened Despite its Friday lurch downwards, the stock market generally had a good week. Not every company on the exchange did well, however, and that list includes Bluebird Bio (NASDAQ: BLUE). The gene-editing specialist's shares fell more than 11% e
Announcement as on 19 August 2022

Gene Editing Stocks To Consider After Bluebird Bio's Breakthroughs
Gene Editing players have had a tough year so far, as the markets continue to sour on high-growth and futuristic stocks amid surging U.S. inflation and rising interest rates. For perspective, our theme on Gene Editing stocks remains down by 37% year-to-dat
Announcement as on 17 June 2022

Where Will Bluebird Bio Be in 1 Year?
The past few years have been harsh on Bluebird Bio (NASDAQ: BLUE). The rare-diseases-focused, gene-therapy specialist ran into a series of clinical and regulatory headwinds, which played a major role in its catastrophic performance in the stock market sinc
Announcement as on 17 April 2022

Is Bluebird Bio a Buy?
With its shares down by around 84% in the past year, it's a wonder that investors are still interested in Bluebird Bio (NASDAQ: BLUE) at all. It withdrew its beta thalassemia drug, Zynteglo, from the E.U. market over persistent pricing conflicts with regul
Announcement as on 15 April 2022

Announcements by Bluebird Bio, Inc. first page | Next page | Prev page |

BLUE Bluebird Bio, Inc. current price & indicator signals

Moving Averages for Bluebird Bio, Inc.

  • 5Day Average: 4.98
  • 12Day Average: 4.98
  • 20Day Average: 4.45
  • 50Day Average: 4.43
  • 100Day Average: 5.3
  • 150Day Average: 4.53
  • 200Day Average: 3.55

BLUE Indicators & signals

Indicator MACD (12,26,9)

4.81, 4.59, 0.16
Indicator MACD is in positive zone

Indicator ADX (14)

11.11, 30.77, 38.46
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 66
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of BLUE Bluebird Bio, Inc. are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
30 Fri May 2025 4.97 4.67 to 5.03 0% 2.03 times
29 Thu May 2025 4.97 4.40 to 4.98 -0.2% 1.13 times
28 Wed May 2025 4.98 4.98 to 5.00 -0.4% 1.43 times
27 Tue May 2025 5.00 4.98 to 5.01 0.2% 1.54 times
23 Fri May 2025 4.99 4.98 to 4.99 0% 0.36 times
22 Thu May 2025 4.99 4.98 to 4.99 0.4% 0.37 times
21 Wed May 2025 4.97 4.97 to 4.99 -0.2% 1.28 times
20 Tue May 2025 4.98 4.97 to 4.99 0% 0.79 times
19 Mon May 2025 4.98 4.97 to 4.99 0.2% 1 times
16 Fri May 2025 4.97 4.97 to 4.99 0% 0.96 times
15 Thu May 2025 4.97 4.97 to 4.99 -0.2% 1.15 times
14 Wed May 2025 4.98 4.95 to 4.99 50.45% 15.39 times

Videos related to: BLUE announcements Bluebird Bio, Inc. announcements and dividends declared USA

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

BLUE announcements Bluebird Bio, Inc. announcements and dividends declared USA

 

Back to top